chrisvoncsefalvay/vaers-outcomes huggingface dataset:
He had a sore right arm after each dose; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (He had a sore right arm after each dose) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041B21A) for COVID-19 vaccination.     The patient's past medical history included Cancer (Patient is a cancer survivor). Concurrent medical conditions included Immunocompromised. Concomitant products included PALBOCICLIB (IBRANCE) and ANASTROZOLE (ANASTRAZOLE DENK) for an unknown indication.    On 13-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (He had a sore right arm after each dose). At the time of the report, PAIN IN EXTREMITY (He had a sore right arm after each dose) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment medication was not provided by the reporter.   This case was linked to MOD-2021-357979, MOD-2021-358010 (Patient Link).
At 10pm on 1/26/21 I experienced severe pain in my right wrist.  The pain kept me awake all night.  In the morning I could not touch my wrist, move it without extreme pain. The pain level was a 10/10.  I made an appointment with a doctor but was not able to be seen until February 24.  I took advil, wrapped it in an ace bandage with no relief.  Around 4:00 pm on 1/27/21, I realized that the pain was gone.  I tried moving my wrist and was able to.  After that I had complete motility and no pain.  Is this related to the vaccine?  I've never experienced this before.
100.5 temp, chills, body aches. Treatment with tylenol and Aleve alternating. Symptoms relieved 36 hours from start. Called into work 3/23/21.
AROUND 4PM HE NOTICED HIS FINGERS TWITCHING MORE THAN USUAL (HAS FAMILY TREMOR) HARD TIME TYPING ON COMPUTER. HIS LEGS WERE "JUMPIN" ALSO (NEVER HAPPENED BEFORE) HE COULD FEEL THE SHAKING & JUMPING. (WITH TREMOR HE DOESN'T) WHEN I TOUCHED L ARM YOU COULD FEEL "SPAZING" IN MUSCLES. HE DIDNT SLEEP WELL. IN AM STILL GOING ON. LUNCH HIS L HAND WAS REALLY TWITCHING GOING UP & DOWN AT WRIST. HIS SANDWICH WAS FLOPPING. MID EVENING NEXT DAY IT WAS GONE.
pt recv vax;devel hives at inject site,distal wrist,arm,trunk & face;also exp a macular rash & erythema around inject site & erythematous papules on elbow & arm;hives resolved 4-5 wk later;
On 03/14/2002 at 12:30pm pt's mother called the office and reported one episode of apnea on 3/13/2002 in pm and 2 episodes that am. continued episodes by 2pm. Infant taken to the hospital and was told that it was reaction that will resolve within 1 week.
This case was reported by a consumer via call center representative and described the occurrence of tingling in a female patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced tingling and numbness. On an unknown date, the outcome of the tingling and numbness were not reported. It was unknown if the reporter considered the tingling and numbness to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The physician told that numbness and tingling were the top 5 side effects for SHINGRIX and that he was aware of 3 nurses that had the same side effect. This case was 1 of the 4 cases, reported by same reporter.
raised red area around lt temple 2 1/2 cm around 1/2cm raised occurred 1hr post vax increased in size for 4 days;
This case was reported by a consumer via call center representative and described the occurrence of fever in a elderly male patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced fever. The patient was treated with TYLENOL. On an unknown date, the outcome of the fever was recovered/resolved. The reporter considered the fever to be probably related to SHINGRIX. Additional details were received as follows: The age at vaccination was not reported. The patient was caller's husband. In 2018, the patient received a dose of SHINGRIX vaccine and had a fever of 100 degrees F. The patient took TYLENOL and fever resolved. This case was linked with US2018124951, reported by the same reporter.
COVID dose 1 - May 27 2021 (Comirnaty Biontech) COVID dose 2 - June 24 2021 (Comirnaty Biontech) COVID dose 3 - December 17 2021 (Moderna Spikevax) COVID dose 4 - October 3 2022 (Comirnaty Biontech)      Mid Oct. Pea size lump felt after this. Mentioned to me on 27th October Surgery : 16 February: 30 cm tumor.  Ductal carcinoma in situ.  Pea sized tumour in right breast noted on 27 October; Surgery on 16 March 2023 to remove a 3 cm malignant tumour. Further testing confirmed diagnosis of ductal carcinoma in situ.
Redness, pain, and swelling on upper arm for 5 days following injection. Then the site became itchy for next two days. Underarm pain on days 3 through 5. Headache started the day after the shot and has continued though now. Fatigue started several hours after the shot and continued for 24 hours.
Client came to clinic and got her flu vaccine. In entering paperwork into system realized that client had received a flu shot back on 10/5/23. Would be a second vaccine within weeks of each other. Called client once we noticed we had given a second vaccine to her and she couldn't recall getting a vaccine at store or not.  does have some memory issues she states.
?Moderna COVID-19 Vaccine EUA,  NAUSEA AND WAS FOUND TO HAVE A BLOOD PRESSURE OF 84/55, HEADACHE, WEAK, BRAIN FOG.  HAD SYMPTOMS FOR SEVERAL DAYS.  EVEN 5 DAYS AFTER THE EVENT I AM NOT ABLE TO TAKE MY FULL DOSE OF BLOOD PRESSURE MEDICATION AS IT DROPS MY BLOOD PRESSURE.  ALSO HAD A SIGNIFICANT REACTION AT THE INJECTION SITE.
Death on 10/26/2005 (found deceased in bedroom), flu vaccination given 10/13/05.  Patient also seen at that time for low-grade fever, crankiness, diarrhea, diagnosed with viral stomatitis given finding of ulcers inside lower lip. 6/20/06 Received medical records from PCP which reveal that on day of vax patient had fever, crankiness, sleep difficulties, diarrhea, decreased oral intake & cold sores of lower lip.  Dx: viral illness & stomatitis.  6/21/06 Received autopsy report which revealed COD as complications of viral infection.  Histology of lungs showed atypical interstitial pneumonitis & brain showed perivascular inflammation consistent with viral infection.  Bacterial & viral cultures were neg.  Neuropath exam revealed focal privascular chronic inflammation consistent with viral encephalopathy./ss
This case was reported by a physician via sales rep and described the occurrence of neurologic reaction in a unk patient who received DTPa (batch number UNKNOWN, expiry date unknown). On an unknown date, the patient received DTPa (subcutaneous). On an unknown date, an unknown time after receiving DTPa, the patient experienced neurologic reaction. On an unknown date, the outcome of the neurologic reaction was unknown. It was unknown if the reporter considered the neurologic reaction to be related to DTPa. Additional details were provided as follows: The product brand was not specified as BOOSTRIX. The patient had suffered a neurological reaction following administration of TDAP vaccine. It was unknown whether the vaccine was administered at the hospital or at a satellite clinic. No other information was available at this time.
had a little bit of sniffles; his eyes were a little weird; he's not feeling well; He was pale; This is a spontaneous report from a contactable consumer or other non hcp (male patient (boyfriend).   A 71-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot No was not reported), via an unspecified route of administration on an unspecified date as 2nddose, single for covid-19 immunisation (Age at vaccination was 71 years). Historical vaccine was A 71-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot No was not reported), via an unspecified route of administration on an unspecified date as 1stdose, single for covid-19 immunisation. He had no side effects after his first shot. The patient medical history and concomitant medications were not reported.  The patient experienced had a little bit of sniffles, his eyes were a little weird, he's not feeling well, he was pale on an unspecified date. She states she could look at him in a second and know he's not feeling well. He was pale, but he is feeling good now also stated her sister's son's father-in-law (65 years old) caught COVID twice and suffered a stroke and got the same treatment that the president received, and he is feeling well. The outcome of had a little bit of sniffles, his eyes were a little weird, he's not feeling well on an was unknown, he was pale was recovering.  Information on lot number/batch number has been requested.  Follow-up attempts are completed. No further information is expected.
vaccine places out of the freezer into fridge on 07-Jun-2023 and was administered on 27-Jul-2023; no adverse event; Administered an expired vaccine; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered an expired vaccine), PRODUCT STORAGE ERROR (vaccine places out of the freezer into fridge on 07-Jun-2023 and was administered on 27-Jul-2023) and NO ADVERSE EVENT (no adverse event) in a 31-year-old patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7184B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 27-Jul-2023, the patient received third dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 27-Jul-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered an expired vaccine). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (vaccine places out of the freezer into fridge on 07-Jun-2023 and was administered on 27-Jul-2023) and NO ADVERSE EVENT (no adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered an expired vaccine), PRODUCT STORAGE ERROR (vaccine places out of the freezer into fridge on 07-Jun-2023 and was administered on 27-Jul-2023) and NO ADVERSE EVENT (no adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Administered an expired vaccine) and PRODUCT STORAGE ERROR (vaccine places out of the freezer into fridge on 07-Jun-2023 and was administered on 27-Jul-2023).    No concomitant medication was reported. The vaccine expired date was reported as 03-Jul-2023.  No treatment medication was reported.
At the time of vaccination I was 27 weeks pregnant. Three days after receiving my vaccine my husband took me to Hospital ER with a concealed placenta abruption. I lost my baby. She was due on 12/09/2021. I do not have any previous history of miscarriages. This was my first pregnancy. I had to have an emergency C-section. I was prescribed hydrocodone, but it was not working. I was given oxycodone and stool softener. I also had to have blood transfusions.
flu like symptoms; This is a spontaneous report from a contactable consumer (patient). A 30-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EH9899), via an unspecified route of administration in right arm on 28Dec2020 at single dose for COVID-19 immunization. Medical history was reported as none. There were no concomitant medications. On the first round of the vaccine the patient experienced flu like symptoms on an unspecified date. The outcome of the event was unknown. The facility where the most recent COVID-19 vaccine was administered was in the hospital.
I did not have a reaction to the vaccine. I tested positive for COVID-19 on 01/26/2023. The first two days I took Tylenol or Advil and that was it. I had a telehealth visit with a provider but did not get a prescription. I am feeling better with no lingering symptoms.
Day 1: Arm pain 5/10, neck stiffness, tension headache 5/10 (occipital and temporal)  Day 2: Arm pain 5/10, neck stiffness, throbbing headache 5/10 (occipital and temporal) Day 3: Arm pain 1/10 Day 4: no symptoms
Warm to the touch knot at the site of injection; Itchy knot at the site of injection; Red knot at the site of injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Warm to the touch knot at the site of injection), VACCINATION SITE PRURITUS (Itchy knot at the site of injection) and VACCINATION SITE ERYTHEMA (Red knot at the site of injection) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Warm to the touch knot at the site of injection), VACCINATION SITE PRURITUS (Itchy knot at the site of injection) and VACCINATION SITE ERYTHEMA (Red knot at the site of injection). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE WARMTH (Warm to the touch knot at the site of injection), VACCINATION SITE PRURITUS (Itchy knot at the site of injection) and VACCINATION SITE ERYTHEMA (Red knot at the site of injection) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.
The patient had a fever of 101.8 with increasing body aches. She was advised to go to the emergency room and her fever was 104 at the time of arrival. The patient received IV fluids and was discharged after being monitored.
not feeling well; This case was reported by a consumer via interactive digital media and described the occurrence of feeling unwell in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On 29th October 2020, the patient received Shingrix. On 30th October 2020, 1 days after receiving Shingrix, the patient experienced feeling unwell. On an unknown date, the outcome of the feeling unwell was unknown.   It was unknown if the reporter considered the feeling unwell to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported. The age group was not reported but was captured as adult as per vaccine indication.  The patient received shingrix vaccine and not feeling well at time of reporting.  The reporter asked whether he/she needs to be isolated or quarantined.
Moderna COVID-19 Vaccine EUA. Sore arm for the first two days (3/30/2021 and 3/31/2021). Headache on the third day (4/1/2021). Took Tylenol on 3/31/2021 and 4/1/2021.
Headaches started about an hour after administration and 2 days after she developed hives, swelling, erythema.
A routine dose of Dtap was ordered and the medical assistant drew up and administered KINRIX-Dtap-IPV. The error was explained to the parent. Impact has been informed and it has been noted that the IPV is invalid. No adverse reactions noted.
he died from coming down with Covid; he died from coming down with Covid; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team.  A male patient received BNT162b2 (BNT162B2 NOS), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown), as dose 4 (booster), single (Batch/Lot number: unknown) and as dose 5 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "leukemia" (unspecified if ongoing), notes: Under unspecified treatment for leukemia. The patient took concomitant medications. The following information was reported: DRUG INEFFECTIVE (death, medically significant), SUSPECTED COVID-19 (death, medically significant), outcome "fatal" and all described as "he died from coming down with Covid". The patient date of death was unknown. Reported cause of death: "he died from coming down with Covid". It was not reported if an autopsy was performed. The reporter stated that he/she understands that chemotherapy and/or immunotherapy treatments may reduce or even eliminate the efficacy of vaccine, even if patient has had all 5 shots (including boosters). The reporter had just lost a friend who had been treated for leukemia when he died from coming down with COVID, even though he had "all of your vaccine shots".  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Reported Cause(s) of Death: he died from coming down with Covid; he died from coming down with Covid
developed mild to moderate COVID; developed mild to moderate COVID; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 13 -old patient received bnt162b2 (COMIRNATY) (Batch/Lot number: unknown) as dose 3 (booster), single, (Batch/Lot number: unknown) as dose 2, single and (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "covid prior to vaccination" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "recovered" and all described as "developed mild to moderate COVID". The event "developed mild to moderate covid" and "developed mild to moderate covid" was evaluated at the physician office visit. The patient underwent the following laboratory tests and procedures: sars-cov-2 test: positive. Therapeutic measures were taken as a result of drug ineffective, covid-19.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Terrible muscle; Joint pain; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Terrible muscle) and ARTHRALGIA (Joint pain) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Feb-2021, the patient experienced MYALGIA (Terrible muscle) and ARTHRALGIA (Joint pain). At the time of the report, MYALGIA (Terrible muscle) and ARTHRALGIA (Joint pain) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.
Narrative: Patienet expereienced paresthesia and MS flare-up after 2 nd dose of vaccine
Several days after receiving the polio vaccination patient developed a bad case of eczema that was on his torso, back, neck, ears, and under arms.
weakness/no energy; headache; canker sores in mouth; arm pain; fever; sweating; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 73-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included aphthous stomatitis.   On 20th February 2020, the patient received the 1st dose of Shingrix. On 20th February 2020, less than a day after receiving Shingrix, the patient experienced pain in arm, fever and sweating. On 21st February 2020, the patient experienced weakness, headache and aphthous stomatitis. The patient was treated with ibuprofen (Advil). On an unknown date, the outcome of the pain in arm, fever, sweating, weakness and headache were recovering/resolving and the outcome of the aphthous stomatitis was unknown.   It was unknown if the reporter considered the pain in arm, fever, sweating, weakness, headache and aphthous stomatitis to be related to Shingrix.  Additional details were provided as follows: The patient felt that her adverse experience was worse because she only weighs 90 pounds.  The patient took Advil the day after receiving her 1st dose of Shingrix and it initially helped to ease the pain, but the pain returned when the Advil wore off.  The patient had a sprained ring finger in November that had healed, but the pain had now returned. The patient did not have any known allergic reactions.  The patient has had canker sores in the past, but she now had recurrent sores in her mouth that were worse than normal. Did not consent to follow-up.
Shortness of breath couldn?t breath,  heart stressed. Symptoms have gotten better after one week, but still  slightly present ten days after second dose.
Patient admitted to the the hospitalist service on 3/6/22 for evaluation and treatment of AMS associated with falls. Polypharmacy most likely secondary to behaviors  - consultation with tele psyche who recommended discontinuation of :  cogentin, risperdal, zanaflex, topamax, and trazadone  - patient was discharge on minimal antipsychotic medications ED visit to hospital admission within 6 weeks of receiving the COVID vaccine.
Generalized seizure after/during the vaccines given happens while in process of administering the 2nd vaccine
RINGING IN THE LEFT EAR; This spontaneous report received from a patient concerned a 55 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included non alcoholic, and non smoker, and other pre-existing medical conditions included patient did not took any medications, no known allergies and drug abuse or illicit drug usage. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 204A21A, expiry: UNKNOWN) dose was not reported, administered on 09-JUL-2021 for prophylactic vaccination. No concomitant medications were reported. On 09-JUL-2021, the subject experienced ringing in the left ear. Treatment medications included: ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from ringing in the left ear on 09-JUL-2021. This report was non-serious.
This spontaneous report as received from a nurse refers to an unspecified number patients of unknown age and gender. On an unknown date in 2014 (reported as since 08-AUG-2014), the patients were vaccinated with (Oka/Merck) VARIVAX which was improperly stored, (strength, dose, lot numbers and route were not reported). No adverse effects were reported. Follow up information has been received from the registered nurse who stated that it will take some time to get the (Oka/Merck) VARIVAX information (patient identifiers, lot numbers, expiration dates and dates and vaccine administration) together and that she may send the information at a later time. Follow up information has been received from the registered nurse concerning a patient (age range reported as 6-12, units not reported) of unknown gender. On 17-SEP-2014, the patient was vaccinated with a dose of (Oka/Merck) VARIVAX which was improperly stored (lot number K005180, expiration date 10-APR-2016; dose number, dose and route were not reported). The reporter stated that this was the information that they could find and provide and anything further would be much too difficult and time consuming due to their record keeping and tracking system. This is one of several reports received from the same reporter. Additional information is not expected because follow up has been obtained.
Fever following vaccines - post 11 days and rash post 5 days vaccine. Dx Mth thrombocytopenia.